– Aktana raises $20M in debt financing from CIBC Innovation Banking for AI-enabled decision support for the global life sciences industry.
– CIBC Innovation Banking delivers strategic advice, cash management, and funding to innovation companies at each stage of their business cycle, from startup to IPO and beyond.
– Using embedded AI and machine learning refined by real-time human insight, Aktana gives life sciences commercial teams the tools and information to anticipate customer needs and coordinate a cohesive experience.
Aktana, an AI-enabled decision support for the global life sciences has closed $20M in debt financing from CIBC Innovation Banking. Aktana equips life science companies with the decision support technology to quickly evaluate mountains of data, extracting only what’s relevant and valuable at the time of decision. CIBC Innovation Banking delivers strategic advice, cash management, and funding to North American innovation companies at each stage of their business cycle, from startup to IPO and beyond. Aktana is backed by HLM Venture Partners, Leerink Partners, SafeGuard Ventures and Starfish Ventures.
AI-Enabled Decision Support for Life Sciences
Founded in 2011, Aktana is the pioneer in AI-enabled decision support for the global life sciences industry. Using embedded AI and machine learning refined by real-time human insight, Aktana gives life sciences commercial teams the tools and information to anticipate customer needs and coordinate a cohesive experience across channels that is relevant, personalized and highly effective. This allows for better engagement between commercial teams and healthcare providers (HCPs) and ultimately better patient care. With its proven framework for intelligent engagement, Aktana has helped more than half of the world’s top-20 pharmaceutical companies put complex data into context, coordinate channel activity, and generate sales lift of up to 15%.
“Led by a team with deep experience in both technology and life sciences, Aktana is developing innovative and intelligent solutions for its customer base of large life sciences companies,” said Jeff Chapman, a Managing Director in CIBC Innovation Banking’s Menlo Park office. “Aktana is disrupting the industry and we’re pleased to support the next stage of the company’s growth.”
